Total Payments
$5,454
2024 Payments
$127.92
Companies
38
Transactions
412
Medicare Patients
14,185
Medicare Billing
$618,010
Payment Breakdown by Category
Food & Beverage$5,432 (99.6%)
Education$21.30 (0.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,432 | 409 | 99.6% |
| Education | $21.30 | 3 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $665.87 | 50 | $0 (2024) |
| PFIZER INC. | $580.77 | 49 | $0 (2024) |
| Amgen Inc. | $494.29 | 43 | $0 (2023) |
| Novo Nordisk Inc | $465.38 | 32 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $308.74 | 21 | $0 (2023) |
| Lilly USA, LLC | $301.58 | 24 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $267.66 | 21 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $266.89 | 19 | $0 (2023) |
| Allergan, Inc. | $252.80 | 18 | $0 (2020) |
| GlaxoSmithKline, LLC. | $205.14 | 16 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $127.92 | 8 | ABBVIE INC. ($52.43) |
| 2023 | $1,004 | 74 | AbbVie Inc. ($229.55) |
| 2022 | $731.69 | 57 | ABBVIE INC. ($173.75) |
| 2021 | $903.72 | 62 | AbbVie Inc. ($121.68) |
| 2020 | $715.39 | 50 | Allergan, Inc. ($174.23) |
| 2019 | $509.31 | 37 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($74.00) |
| 2018 | $535.21 | 42 | Takeda Pharmaceuticals U.S.A., Inc. ($61.64) |
| 2017 | $927.03 | 82 | GlaxoSmithKline, LLC. ($109.01) |
All Payment Transactions
412 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/08/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: NEUROSCIENCE | ||||||
| 08/26/2024 | PFIZER INC. | COMIRNATY (Biological), ABRYSVO | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: VACCINES | ||||||
| 07/22/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $18.50 | General |
| Category: NEUROSCIENCE | ||||||
| 06/04/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: VACCINES | ||||||
| 03/25/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: VACCINES | ||||||
| 03/18/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: NEUROSCIENCE | ||||||
| 03/06/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: VACCINES | ||||||
| 01/16/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: Gastroenterology | ||||||
| 12/20/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $1.77 | General |
| Category: NEUROSCIENCE | ||||||
| 12/15/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: Obesity | ||||||
| 12/07/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | SYNJARDY (Drug) | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: DIABETES | ||||||
| 12/04/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.04 | General |
| Category: Inflammation | ||||||
| 11/29/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.23 | General |
| Category: NEUROSCIENCE | ||||||
| 11/28/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $10.31 | General |
| Category: PAIN | ||||||
| 11/16/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $9.89 | General |
| Category: Cardiology | ||||||
| 11/15/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: Gastroenterology | ||||||
| 11/09/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: Diabetes | ||||||
| 11/06/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: Obesity | ||||||
| 10/26/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: NEUROSCIENCE | ||||||
| 10/09/2023 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $10.04 | General |
| Category: Bone Health | ||||||
| 10/05/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug) | Food and Beverage | In-kind items and services | $13.45 | General |
| Category: DIABETES | ||||||
| 09/28/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: Respiratory | ||||||
| 09/25/2023 | AbbVie Inc. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $11.96 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/21/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.05 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 42 | 3,912 | 5,237 | $401,931 | $168,011 |
| 2022 | 47 | 3,757 | 4,810 | $343,648 | $158,202 |
| 2021 | 41 | 3,399 | 4,600 | $334,928 | $156,576 |
| 2020 | 35 | 3,117 | 4,256 | $310,430 | $135,222 |
Total Patients
14,185
Total Services
18,903
Medicare Billing
$618,010
Procedure Codes
165
All Medicare Procedures & Services
165 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 298 | 513 | $104,652 | $37,323 | 35.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 260 | 260 | $42,900 | $30,871 | 72.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 183 | 398 | $52,536 | $21,365 | 40.7% |
| 91322 | Sarscov2 vac 50 mcg/0.5ml im | Office | 2023 | 62 | 62 | $9,300 | $8,866 | 95.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 112 | 112 | $8,176 | $8,000 | 97.9% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 277 | 277 | $9,141 | $4,703 | 51.5% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 27 | 29 | $8,613 | $4,180 | 48.5% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 226 | 226 | $7,458 | $3,837 | 51.5% |
| 0134A | Adm sarscv2 bvl 50mcg/.5ml a | Office | 2023 | 97 | 100 | $4,400 | $3,774 | 85.8% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 259 | 274 | $12,056 | $3,582 | 29.7% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 279 | 334 | $14,696 | $3,454 | 23.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 117 | 117 | $4,914 | $3,346 | 68.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 185 | 358 | $5,012 | $2,980 | 59.5% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 19 | 19 | $3,667 | $2,804 | 76.5% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 281 | 357 | $13,923 | $2,709 | 19.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 20 | 21 | $5,313 | $2,644 | 49.8% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 12 | 12 | $3,900 | $2,454 | 62.9% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 62 | 62 | $2,480 | $2,363 | 95.3% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 102 | 123 | $7,626 | $2,025 | 26.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 30 | 198 | $9,900 | $1,834 | 18.5% |
| 82306 | Vitamin d-3 level | Office | 2023 | 46 | 52 | $5,148 | $1,509 | 29.3% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 40 | 43 | $11,825 | $1,491 | 12.6% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 11 | 11 | $2,244 | $1,451 | 64.7% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 114 | 148 | $6,512 | $1,399 | 21.5% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 72 | 72 | $4,968 | $1,362 | 27.4% |
About Dr. Keith Wright, M.D
Dr. Keith Wright, M.D is a Family Medicine healthcare provider based in Manhattan, Kansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1174562227.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Keith Wright, M.D has received a total of $5,454 in payments from pharmaceutical and medical device companies, with $127.92 received in 2024. These payments were reported across 412 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($5,432).
As a Medicare-enrolled provider, Wright has provided services to 14,185 Medicare beneficiaries, totaling 18,903 services with total Medicare billing of $618,010. Data is available for 4 years (2020–2023), covering 165 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Other Specialties Sports Medicine
- Location Manhattan, KS
- Active Since 06/05/2006
- Last Updated 07/25/2013
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1174562227
Products in Payments
- VRAYLAR (Drug) $447.66
- Vascepa (Drug) $199.13
- TRULICITY (Drug) $178.25
- EVENITY (Biological) $174.16
- JARDIANCE (Drug) $160.71
- UBRELVY (Drug) $156.40
- NURTEC ODT (Drug) $151.62
- ELIQUIS (Drug) $130.76
- Ozempic (Drug) $130.68
- XIFAXAN (Drug) $130.18
- Otezla (Drug) $124.26
- BREZTRI (Drug) $117.59
- TRINTELLIX (Drug) $111.40
- FARXIGA (Drug) $110.89
- QULIPTA (Drug) $106.95
- Wegovy (Drug) $101.11
- PREVNAR 13 (Biological) $100.64
- VYVANSE (Drug) $92.49
- Rybelsus (Drug) $89.94
- XARELTO (Drug) $87.85
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Manhattan
Bradley Harrison, M.d, M.D
Family Medicine — Payments: $451,744
Family Medicine $451,744
Dr. Kent Kiracofe, M.d, M.D
Family Medicine — Payments: $186,788
Family Medicine $186,788
Dr. Kyle Platz, D.o, D.O
Family Medicine — Payments: $52,764
Family Medicine $52,764
Bethany Duff, Md, MD
Family Medicine — Payments: $8,727
Family Medicine $8,727
Dr. Cary Herl, Md, MD
Family Medicine — Payments: $8,424
Family Medicine $8,424
Dr. Jacqi Lambert, M.d, M.D
Family Medicine — Payments: $8,316
Family Medicine $8,316